|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 6.510 SEK | -3.84% |
|
+0.77% | +16.25% |
| 09-16 | Mendus Launches Early-stage Trial for Acute Myeloid Leukemia Treatment Combo | MT |
| 09-16 | Mendus launches Phase 1b study with vididencel | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MENDUS AB | Other Biotechnology & Medical Research | -3.84% | +0.77% | +16.25% | -0.61% | -92.25% | 43.53M |  |  |  |
- Stock Market
- Stocks
- IMMU Stock
- Charts Mendus AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
